
Zimmer Biomet Holdings ZBH
$ 103.42
1.22%
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
198 M |
Market Cap[1] |
$ 20.5 B |
EBITDA (LTM) |
$ 1.83 B |
P/E (LTM) |
27.803526 |
P/S (LTM) |
2.550084 |
EPS (LTM) |
3.97 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Penumbra
PEN
|
$ 320.36 | 0.39 % | $ 12.5 B | NYSE,SPB | ||
|
Venus Concept
VERO
|
- | - | $ 726 K | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
SeaSpine Holdings Corporation
SPNE
|
- | 0.28 % | $ 270 M | Nasdaq Global Select Market | ||
|
Inari Medical
NARI
|
- | - | $ 4.23 B | Nasdaq Global Select Market,SPB | ||
|
Viemed Healthcare
VMD
|
$ 8.81 | -2.87 % | $ 343 M | Nasdaq Global Select Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 139.95 | -3.71 % | $ 9.85 B | Nasdaq Global Select Market,SPB | ||
|
ViewRay
VRAY
|
- | 1.54 % | $ 468 M | Nasdaq Global Select Market | ||
|
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Nasdaq Global Select Market | ||
|
Vapotherm
VAPO
|
- | 6.72 % | $ 34 M | NYSE | ||
|
Silk Road Medical, Inc
SILK
|
- | - | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
TELA Bio
TELA
|
$ 0.78 | 2.43 % | $ 36.6 M | Nasdaq Global Select Market | ||
|
Zynex
ZYXI
|
- | - | $ 21.1 M | Nasdaq Capital Market,SPB | ||
|
TransMedics Group
TMDX
|
$ 96.58 | 2.84 % | $ 3.28 B | Nasdaq Global Market | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nemaura Medical
NMRD
|
- | -17.8 % | $ 2.74 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 6.11 | 6.0 % | $ 1.51 B | NYSE | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Abbott Laboratories
ABT
|
$ 104.47 | -0.23 % | $ 182 B | NYSE,SPB | ||
|
Align Technology
ALGN
|
$ 163.89 | 0.26 % | $ 11.9 B | Nasdaq Global Select Market,SPB | ||
|
Alphatec Holdings
ATEC
|
$ 7.08 | 1.95 % | $ 1.06 B | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 43.66 | 1.45 % | $ 64.6 B | NYSE,SPB | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.93 | 1.34 % | $ 578 M | Nasdaq Global Select Market,SPB | ||
|
Aethlon Medical
AEMD
|
$ 5.05 | -0.59 % | $ 3.4 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 369.72 | 3.22 % | $ 10.1 B | NYSE,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 2.44 | -4.5 % | $ 100 M | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 48.11 | -0.59 % | $ 1.49 B | NYSE,SPB | ||
|
Establishment Labs Holdings
ESTA
|
$ 70.8 | 1.86 % | $ 2.1 B | Nasdaq Capital Market | ||
|
Medtronic PLC
MDT
|
$ 100.7 | -1.58 % | $ 129 B | NYSE,SPB | ||
|
Myomo
MYO
|
$ 0.88 | -3.85 % | $ 36.8 M | NYSE American | ||
|
MiMedx Group
MDXG
|
$ 3.2 | 0.63 % | $ 473 M | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 19.7 | 1.7 % | $ 706 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 23.59 | 1.99 % | $ 195 M | NYSE American | ||
|
Inogen
INGN
|
$ 5.58 | -1.85 % | $ 148 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 70.5 | 0.73 % | $ 9.53 B | NYSE,SPB | ||
|
Quanterix Corporation
QTRX
|
$ 2.07 | -27.62 % | $ 88.3 M | Nasdaq Global Select Market,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 82.34 | -1.33 % | $ 1.05 B | Nasdaq Global Select Market | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 0.26 | -8.45 % | $ 16.8 M | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 7.77 | -1.21 % | $ 220 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 2.49 | 2.05 % | $ 305 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.